NY scraps race-based STEM program after Asians claim discrimination
The state-funded Science and Technology Entry Program (STEP) admits 11,000 seventh- to 12th-grade students a year for classes at 56 participating colleges and medical schools statewide, with a related College Science and Technology Entry Program (CSTEP).
The pre-college enrichment program aims to 'increase the number of historically underrepresented and economically disadvantaged students prepared to enter college and improve their participation rate' in math, science, tech and health fields, according to its website.
Advertisement
3 Yiatin Chu, a co-founder of the Asian Wave alliance, praised the decision by New York state education officials to scrap a race-based admissions policy for advanced STEM classes.
James Messerschmidt
But while black, Hispanic and Native American students could apply regardless of family wealth, Asian and white schoolkids needed to meet certain income criteria — indicating they are economically challenged — or be excluded.
A federal lawsuit filed in January accused New York of engaging in blatant discrimination against Asian and white students under the program.
Advertisement
'Progress!' crowed Yiatin Chu — a co-founder of the Asian Wave alliance who said her daughter was one of the students discriminated against because of the race-based policy — to The Post.
Chu said her then-seventh-grade daughter was 'able and ready' to apply for admission to the summer 2024 STEP program at New York University but couldn't 'because her race makes her ineligible.
'It was unfair and racist for my daughter to be subjected to a low-income requirement just because she is Asian when her black and Hispanic classmates weren't,' Chu said Sunday. 'I'm glad that my lawsuit instigated revisiting these decades long, race-based standards.'
Another Asian parent said her daughter was enrolled in 11th grade abd had an overall grade-point average above 80 in math, science, and English but was 'unable to complete an application for admission' to CUNY's Baruch College 'because she was required to satisfy a family income threshold.
Advertisement
3 Chu said her daughter wasn't able to apply for the summer 2024 STEP program because of her race.
J.C.Rice
'I instead paid thousands of dollars to enroll her in an alternative summer science program,' said the parent, who asked not to be identified.
A top state education official, noting the still-pending litigation over the program, has already urged directors and administrators of STEP and CSTEP to stop using race or 'historically underrepresented minority status' to determine admissions and instead use only family income as admission criteria.
'As many of you are aware, the New York State Education Department (NYSED) is currently
engaged in active litigation concerning the eligibility criteria for participation in the Science and
Technology Entry Program (STEP),' wrote Anael Alston, the education department's assistant commissioner of the Office of Access, said in a July 8 memo to directors and administrators.
Advertisement
'The litigation challenges certain aspects of our longstanding eligibility guidelines related to student race and ethnicity,' Alston said.
'While NYSED remains committed to defending the STEP and CSTEP programs and their historic mission to increase access and opportunity for historically underrepresented students in the scientific, technical, and health-related professions, we recognize the need to provide clarity and support to the field during this period of legal uncertainty.'
The new guidance from Alston said 'effective immediately and until further notice, STEP and CSTEP grantees may determine student eligibility without regard to historically underrepresented minority status, race, or ethnicity.'
'Instead, grantees are encouraged to base eligibility decisions solely on indicators of economic disadvantage, in alignment with applicable state and federal guidelines,' Alston wrote.
'Recruitment, selection, and enrollment of new students may proceed using economic-based
eligibility criteria only. Collection or use of race, ethnicity, or minority status data is not required for eligibility.'
But Alston also appeared to defend the mandatory race-based admission policy she just eliminated.
'NYSED will continue to vigorously defend the mission and intent of STEP and CSTEP in court,' the official said.
Advertisement
The lawyers for the opposing Asian parents said state officials capitulated because they know the race-based policy is illegal. But the parents' reps complained that state officials still left wiggle room to continue discriminating against students by using words such as 'may' and 'encouraged.'
3 A federal lawsuit filed in January accused New York of engaging in blatant discrimination against Asian and white students under the program.
Andrew Schwartz / SplashNews.com
'The state of New York has raised the white flag of surrender in our lawsuit, but not high enough,' said
William Jacobson, founder of EqualProtect.org.
Advertisement
'Word games are not acceptable,' Jacobson said. 'The state must do away with the racially discriminatory eligibility requirements completely and permanently, or we will ask the court to order it.'
Erin Wilcox, a senior lawyer at Pacific Legal Foundation, said, 'The state should be requiring all schools to stop this illegal discrimination immediately, not giving them the option to continue.'
In 1985, New York lawmakers passed legislation aimed at boosting interest in STEM and healthcare among low-income and underrepresented minority students.
But racial-preference programs — aimed at correcting historic injustices or underrepresentation of blacks and other minorities — have come under the microscope after the US Supreme Court last year struck down college affirmative action programs aimed at boosting minority representation as discriminatory.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New York Post
3 hours ago
- New York Post
Dozens injured, including child, in Russian strikes using new type of bomb being tested on civilians
KHARKIV, Ukraine — Thirty-three civilians — including a 10-year-old and two teenagers — were wounded in strikes Thursday in Kharkiv, where Russian forces are testing out a new type of 'glide bomb' on innocent people. The Post was on scene as war crimes investigators, firefighters, humanitarian and emergency services arrived just minutes after the back-to-back strikes, which hit a residential apartment building and a textiles factory around 11:15 a.m. local time. 'I was just coming from my kitchen when I heard the bomb,' building resident Svetlana Shevcheko said. 'I never thought about leaving Kharkiv before, but I am thinking now.' 5 Thirty-three civilians were wounded in strikes in Kharkiv, where Russian forces are testing out a new type of 'glide bomb.' Edoardo Marangon/ZUMA Press Wire / 5 Residents leave the site of a Russian air strike. REUTERS The northeastern Ukrainian city is just 15 miles from the Russian border, so bombs and missiles can strike into the city before residents are alerted to an incoming air raid. The strike used a new kind of glide bomb, which is a repurposed Soviet-era weapon outfitted with aerodynamic wings for more targeted precision and range. The new bombs used in Kharkiv have a range of somewhere between 90 and 100 km — an increase of about 10 to 20 km — allowing Russia to strike further into the city. 5 The new bombs used in Kharkiv have a range of somewhere between 90 and 100 km, allowing Russia to strike further into the city. Edoardo Marangon/ZUMA Press Wire / 5 The glide bomb is a repurposed Soviet-era weapon with more targeted precision and range. REUTERS 5 The back-to-back strikes hit a residential apartment building and a textiles factory around 11:15 a.m. local time. REUTERS 'They are testing this out on civilians,' chief war crimes prosecutor for the Kharkiv district Spartak Borisenko told The Post. 'Patriot [air-defense systems, made by the US] are the only way to strike them down. The bombs carried 250 kg worth of explosives, he said, creating a blast radius of 500 meters.
New York Post
4 hours ago
- New York Post
Deputy AG Todd Blanche will meet with Ghislaine Maxwell within hours, sources say
Deputy Attorney General Todd Blanche will meet with Jeffrey Epstein accomplice and convicted sex pest Ghislaine Maxwell today in Florida, sources familiar with the matter confirmed to The Post. Blanche, the second-in-command at the Justice Department who has served as president Trump's personal lawyer, plans to huddle with the disgraced ex-socialite and her lawyer at the US Attorney's Office in Tallahassee, the sources said. 3 Todd Blanche speaks at a White House press briefing. Ron Sachs/CNP / 3 Mugshot of Ghislaine Maxwell. Maxwell, a disgraced British socialite who was found guilty of child sex trafficking and other crimes, is serving a 20-year prison sentence after a jury convicted her of grooming young girls by serving as Epstein's madam. But amid a renewed outcry for more information on Epstein, Blanche said earlier this week that he'd be meeting with Maxwell to see if she would be willing to reveal more to feds about the late sex offender. 3 Jeffrey Epstein and Ghislaine Maxwell at a party in NYC on March 15, 2005. Patrick McMullan via Getty Images The DOJ in 2022 expressed doubts that Maxwell could be truthful, accusing her in court papers of a 'significant pattern of dishonest conduct' and failing to take responsibility for her heinous crimes. The feds also disclosed in court papers ahead of her 2021 trial that prosecutors had never seriously entertained working out a plea deal with Maxwell in exchange for her testimony.
Medscape
4 hours ago
- Medscape
Family History Shapes Psoriatic Disease Onset in PsA
TOPLINE: Patients with psoriatic arthritis (PsA) who had a family history of psoriatic disease were diagnosed with psoriasis and PsA earlier and showed more entheseal involvement than those without such family history. METHODOLOGY: Researchers enrolled 843 patients with PsA (mean age, 50.8 years; 50.6% men; 76.4% White individuals) from the New York University (NYU) Psoriatic Arthritis Center and associated clinics in an observational, longitudinal registry to study familial aggregation and differences in disease onset and phenotype. They collected data on demographics, medical and family history, and psoriatic phenotype and activity. Patients were categorized on the basis of family history, with 379 participants having one or more first-degree or second-degree relatives with psoriatic disease (301 had relatives with psoriasis, and 78 had relatives with PsA) and 464 having no history. Disease measures included the age at which psoriasis and PsA were diagnosed, types and locations of psoriasis, and areas affected by PsA. TAKEAWAY: Patients with a family history of psoriatic disease were diagnosed with psoriasis and PsA earlier than those without (mean age, 27.6 vs 32.2 years and 37.6 vs 40.3 years, respectively; P < .01 for both). Patients with first-degree or second-degree relatives with PsA were diagnosed with psoriasis and PsA earlier than those with relatives with psoriasis alone or no family history (P < .01 and P = .01, respectively). Patients with a family history of psoriatic disease were more likely to have a history of enthesitis than those without (36.7% vs 30.0%; P < .05) and active enthesitis at baseline (30.1% vs 21.6%; P < .01). The transition time between the diagnosis of psoriasis and PsA was longer among patients with two or more first-degree or second-degree relatives than among those with only one relative or those with no family history (mean time to diagnosis, 14.1 vs 8.0 vs 8.8 years; P < .01). IN PRACTICE: 'Additional studies integrating molecular and immune features are needed to elucidate how genetic, environmental, and epigenetic elements influence the progression from psoriasis to PsA, as well as PsA's clinical presentation, severity, and therapeutic response,' the authors of the study wrote. SOURCE: The study was led by Catherine Howe, MD, NYU Grossman School of Medicine, New York City. It was published online on July 14, 2025, in Arthritis & Rheumatology. LIMITATIONS: The study relied on patient-reported data for age of diagnosis and family history, which may introduce potential recall bias and underdiagnosis of mild cases. Having a family history may not equate to genetic burden. The lack of a uniform baseline visit for all patients with PsA may affect the assessment of disease activity. DISCLOSURES: This study was funded by grants to authors from the National Institute of Arthritis and Musculoskeletal and Skin Diseases, the NYU Colton Center for Autoimmunity, the Rheumatology Research Foundation, the National Psoriasis Foundation, and other sources. Two authors reported receiving support from an Institutional National Research Service Award and the National Institute of Diabetes and Digestive and Kidney Diseases. Some authors reported receiving consulting fees from or serving on advisory boards for pharmaceutical companies that market drugs for psoriatic disease. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.
